Advertisement
Home »

Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor.

Mar 07, 2024

ABOUT THE EXPERTS

  • Jennifer T Duong

    Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, University of California San Francisco School of Medicine, San Francisco, CA, USA. Electronic address: Jennifer.duong@ucsf.edu.

    Christopher E Pope

    Department of Microbiology, University of Washington School of Medicine, Seattle, WA, USA.

    Hillary S Hayden

    Department of Microbiology, University of Washington School of Medicine, Seattle, WA, USA.

    Carson Miller

    Department of Microbiology, University of Washington School of Medicine, Seattle, WA, USA.

    Stephen J Salipante

    Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, USA.

    Steven M Rowe

    Department of Medicine and the Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, AL, USA.

    George M Solomon

    Department of Medicine and the Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, AL, USA.

    David Nichols

    Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children’s Research Institute, Seattle, WA, USA and Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.

    Lucas R Hoffman

    Department of Microbiology and Department of Pediatrics, Division of Pulmonary and Sleep Medicine, University of Washington School of Medicine, Seattle, WA, USA.

    Michael R Narkewicz

    Digestive Health Institute, Children’s Hospital Colorado and Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado SOM, Aurora, CO, USA.

    Nicole Green

    Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Washington School of Medicine, Seattle, WA, USA.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement